Abstract: Provided are the organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M, X1 to X4, X11, ring CY2 to ring CY4, T1, T2, R1 to R4, and a1 to a4 in Formula 1 are the same as described in the present specification.

Abstract: A heterocyclic compound represented by Formula 1 and an organic light-emitting device the heterocyclic compound represented by Formula 1: wherein, in Formula 1, Cz1 is a group represented by Formula 1A, Het1 is a group represented by Formula 1B, wherein, R1 to R10, R20, R30, R40, R50, and b10 to b50 are each independently the same as described in the detailed description of the specification.

Abstract: An organometallic compound represented by Formula 1, wherein M1 is beryllium, magnesium, aluminum, calcium, titanium, manganese, cobalt, copper, zinc, gallium, germanium, zirconium, ruthenium, rhodium, palladium, silver, rhenium, platinum, or gold; A1 to A3 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; A4 is a 5-membered heterocyclic group; A5 is at least two rings of a C7-C30 carbocyclic group comprising a 6-membered carbocyclic group, or A5 is at least two rings of a C1-C30 heterocyclic group comprising a 6-membered carbocyclic group or a 6-membered heterocyclic group; X10, X20, X30, and X40 to X44 are each independently C or N; T1 to T3 are each independently a single bond, *—N[(L1)a1-(R1)b1]—*?, *—B(R1)—*?, *—P(R1)—*?, *—C(R1)(R2)—*?, *—Si(R1)(R2)—*?, *—Ge(R1)(R2)—*?, *—S—*?, *—Se—*?, *—O—*?, *—C(?O)—*?, *—S(?O)—*?, *—S(?O)2—*?, *—C(R1)?C(R2)—*?, *—C(?S)—*?, or *—C?C—*?; and wherein the other substituents may be understood by referring to the detailed description.

Abstract: An organometallic compound represented by Formula 1: wherein, M is a transition metal, X11 is N or C(R11), X12 is N or C(R12), at least one of X11 and X12 is N, ring CY2, ring CY31, ring CY32, and ring CY4 are each independently a C3-C60 carbocyclic group or a C1-C60 heterocyclic group, Y2 to Y4 are each independently C or N, A2 to A4 are each independently a chemical bond, O, or S, a1 to a3 are each independently an integer from 1 to 3, and the remaining substitutions are as provided in the detailed description.

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Abstract: Provided are the organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M, X1 to X4, X11, ring CY2 to ring CY4, T1, T2, R1 to R4, and a1 to a4 in Formula 1 are the same as described in the present specification.

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound are provided: M1(L11)n11(L12)n12??Formula 1 wherein, in Formula 1, L11 may be a ligand represented by Formula 1-1, and the other substituents may be understood by referring to the descriptions thereof provided in the detailed description:

Abstract: There are provided a composition, a light-emitting device including the composition, and an electronic apparatus including the light-emitting device, wherein the composition includes a first compound including at least one pyrrole-containing condensed cyclic group and a silicon-containing group, and not including an electron-transporting moiety, and a second compound including an azine group including at least one nitrogen, and not including a silicon-containing group.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M11(L11)n11(L12)n12??Formula 1 wherein, in Formula 1, M11 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L11 is a ligand represented by Formula 1-1, L12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein, in Formula 1-1, Y11, A11, T11 k11, k12, k13, b11, E11 to E13 and R11 to R17 are described in the specification, and *1 to *4 each independently indicate a binding site to M11.

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Abstract: An organometallic compound, represented by Formula 1: wherein, M1 is a transition metal, X10, X11, X20, X30, and X40 are each independently C or N, provided that one of X10 and X11 is N, and the other of X10 and X11 is C, ring A10 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, wherein each of X12 and X13 is C, or when ring A10 is not present, X12 is C(R11) and X13 is C(R12), ring A11 is a pyrazole ring or an imidazole ring, rings A20, A30, and A40 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, and at least one of R10, R11, R12, R20, R30, or R40 is a group represented by Formula 2: wherein the remaining substituent groups are as described herein.

Abstract: Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same: wherein the detailed description of Formula 1 is the same as described in the present specification.

Abstract: An organometallic compound, represented by Formula 1: wherein M1 is a transition metal; X10 is C; X11 to X14, X20, X30 to X36, and X40 are each independently C or N; ring A20 and ring A40 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; and R1 to R5, R10, R20, R31, R32, R40, R51, R52, T1, b10, b20, b31, b32, and b40 are as defined herein.

Abstract: An organic light-emitting device including a predetermined host and a thermally activated delayed fluorescence emitter.

Abstract: An organometallic compound represented by Formula 1: M1(L11)n11(L12)n12??Formula 1 wherein, in Formula 1, M1 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L11 is a ligand represented by Formula 1-1, L12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein ring CY1 to ring CY4, E1, T1 to T4, R10 to R40, X1 to X4, n1 to n4, a1 to a4, and c10 to c40 may each be understood by referring to the descriptions thereof provided herein, and *1, *2, *3, and *4 are each a binding site to M1 in Formula 1.

Abstract: Presented is an organic light-emitting device including a host, a dopant, and a sensitizer.

Abstract: A material synthesis apparatus includes: at least one device configured to synthesize a material; a user interface configured to obtain information on a target product; and a processor, wherein the processor is configured to: determine synthesis conditions for preparing the target product using a pretrained synthesis prediction model; calculate a first synthesis method for preparing the target product based on the synthesis conditions; and control the at least one device based on the first synthesis method.

Abstract: An organometallic compound represented by Formula 1: M(L1)n1(L2)n2(L3)n3??Formula 1 wherein in Formula 1, M, L1, L2, L3, n1, n2, and n3 are the same as defined in the specification.

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M1(L11)n11(L12)n12 ??Formula 1 wherein L11 in Formula 1 is a ligand represented by Formula 1-1: wherein, in Formula 1-1, Ar1 is a phenyl group substituted with at least one of E1 and Ar2 is a phenyl group substituted with at least one E2, and the other substituents are described in the detailed description of the present specification.